These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10775601)

  • 1. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
    Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
    J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.
    Schlereth B; Buonocore L; Tietz A; Meulen VT; Rose JK; Niewiesk S
    J Gen Virol; 2003 Aug; 84(Pt 8):2145-2151. PubMed ID: 12867646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).
    Niewiesk S
    Vaccine; 2001 Mar; 19(17-19):2250-3. PubMed ID: 11257342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.
    Kim D; Martinez-Sobrido L; Choi C; Petroff N; García-Sastre A; Niewiesk S; Carsillo T
    J Virol; 2011 Jan; 85(1):200-7. PubMed ID: 20962092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
    Pasetti MF; Barry EM; Losonsky G; Singh M; Medina-Moreno SM; Polo JM; Ulmer J; Robinson H; Sztein MB; Levine MM
    J Virol; 2003 May; 77(9):5209-17. PubMed ID: 12692223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
    Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
    J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.
    Julik E; Reyes-Del Valle J
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28934110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
    Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
    J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection.
    Schlereth B; Germann PG; ter Meulen V; Niewiesk S
    J Gen Virol; 2000 May; 81(Pt 5):1321-5. PubMed ID: 10769075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
    Capozzo AV; Ramírez K; Polo JM; Ulmer J; Barry EM; Levine MM; Pasetti MF
    J Immunol; 2006 May; 176(9):5671-81. PubMed ID: 16622037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model.
    Weidinger G; Ohlmann M; Schlereth B; Sutter G; Niewiesk S
    Vaccine; 2001 Apr; 19(20-22):2764-8. PubMed ID: 11282186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies.
    van Binnendijk RS; Poelen MC; van Amerongen G; de Vries P; Osterhaus AD
    J Infect Dis; 1997 Mar; 175(3):524-32. PubMed ID: 9041322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cotton rats for preclinical evaluation of measles vaccines.
    Wyde PR; Stittelaar KJ; Osterhaus AD; Guzman E; Gilbert BE
    Vaccine; 2000 Aug; 19(1):42-53. PubMed ID: 10924785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
    Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
    J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotton rats (Sigmodon hispidus): an animal model to study the pathogenesis of measles virus infection.
    Niewiesk S
    Immunol Lett; 1999 Jan; 65(1-2):47-50. PubMed ID: 10065626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis.
    Brinckmann UG; Bankamp B; Reich A; ter Meulen V; Liebert UG
    J Gen Virol; 1991 Oct; 72 ( Pt 10)():2491-500. PubMed ID: 1833505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.
    Durbin AP; Skiadopoulos MH; McAuliffe JM; Riggs JM; Surman SR; Collins PL; Murphy BR
    J Virol; 2000 Aug; 74(15):6821-31. PubMed ID: 10888621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
    Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
    Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.